GVR Report cover Cold Form Blister Packaging Market Size, Share & Trends Report

Cold Form Blister Packaging Market Size, Share & Trends Analysis Report By Material (Oriented-polyamide, Aluminum, PVC, PP, PE, PET), By Application (Healthcare, Electronics & Semiconductors), And Segment Forecasts, 2021 - 2028

  • Report ID: GVR-1-68038-141-2
  • Number of Pages: 150
  • Format: Electronic (PDF)

Report Overview

The global cold form blister packaging market size was valued at USD 3.43 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 6.5% from 2021 to 2028. The exceptional features associated with the cold form blister packaging include a complete barrier against water vapor, gases, and light, excellent thermo-formability, high degree of thermal stability, and high malleability for deep drawing blister cavities, sealable with normal aluminum foil, and effective anti-counterfeit packaging. These are the major features driving the demand for cold form blister packaging. Cold form blister packaging is performed on cold forming foil and the usage of the cold-forming technique prevents the use of any kind of heat applications on the packaging. It uses cold-forming foils or sheets of laminate film that contain aluminum, which is typically stamped to force them into the required form by the blister machine. They find major applications in the primary packaging of pharmaceuticals, including tablets and capsules.

U.S. cold form blister packaging market size, by material, 2018 - 2028 (USD Million)

The U.S. market for cold form blister packaging is dominated by healthcare applications including orally administered capsules and tablets. The high demand for medications in the country is primarily supporting the market growth. According to research published by “7The Commonwealth Fund” in 2017, per capita spending on prescription drugs is much higher in the U.S. than in the other high-income countries such as Australia, Canada, France, Germany, the Netherlands, Norway, Sweden, Switzerland, and the U.K.

Cold form blister packaging has high potential demand across the healthcare sector around the globe owing to its usage benefits in terms of functionality in pharmaceuticals. The use of aluminum cold forming foil offers a full barrier to moisture, light, and gasses including oxygen, which allows an extended shelf life of the packed item. As a result, the use of aluminum is dominating in cold form blister packaging of pharmaceuticals.

There are some disadvantages associated with cold form blister packaging. It takes more production time compared to thermoforming, opaque packaging complicates the inspection procedure, and the cost of cold forming aluminum film is higher than PVC. These factors consequently increase the material cost with an increase in the size of the blister card. These are the factors projected to restrict the growth of the global market.

In order to overcome the aforementioned factors, major players are advancing their cold form blister packaging offerings to meet the changing demand of the customers. Additionally, the continuous research and development in the packaging foils are projected to support the market growth in the forecast period.

Material Insights

The aluminum segment held the largest revenue share of over 40.0% in 2020 and it is projected to maintain its lead throughout the forecast period. The aluminum foil is sandwiched between the PVC and Nylon films by using dry bond lamination. The use of aluminum foil offers a barrier to water, light, and oxygen, which extends the shelf life of the product till the expiry date. The majority of the revenue share for aluminum material is contributed by the healthcare sector.

The increasing prevalence of chronic diseases owing to the changing lifestyle of the people, hectic work-life schedules, inactive lifestyles, and unhealthy eating habits are supporting the high demand for drugs to treat the illnesses that occurred due to such habits. According to the National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), six out of 10 Americans have at least one chronic disease like heart disease, cancer, or diabetes. This leads to the USD 3.8 trillion nation’s annual health care costs.

Additionally, the growing geriatric population leads to the dependency on varied medications for dealing with the deteriorating normal functionalities of the aging body, which further supports the demand for cold form blister packaging in the healthcare sector. According to the WHO, the world's population proportion over 60 years will nearly double from 12% to 22% between 2015 and 2050. By 2030, one out of six people across the globe will be aged 60 years or more than that.

The drugs consisting of active pharmaceutical ingredients (APIs) are highly moisture-sensitive because of their complex structures and may result in unwanted physical, chemical, or pharmacological changes when exposed to moisture. In order to keep them safe, cold form blister packaging is used for complete protection and prevention of exposure to the humid environment, thus the drugs have a higher demand for cold form blister packaging consisting of aluminum foil.

The polyvinyl chloride (PVC) material segment is projected to register the fastest CAGR of 7.0% from 2021 to 2028. The cost-effective feature of PVC makes it an essential material in cold-form blister packaging. The ability to increase the strength of the packaging is another factor supporting the usage of PVC in cold form blister packaging. Basically, PVC is used as the contact layer and seal to the alu-alu foil because it is very stiff and ensures geometric stability after cold forming.

Application Insights

The healthcare segment accounted for the largest revenue share of over 60.0% in 2020. The healthcare segment is inclusive of drug packaging that is orally administered including tablets, capsules, and inhaler medication. The widely used material for cold form blister packaging in the healthcare sector is aluminum.

Aluminum foil is used in cold-form blister packaging because of its wide range of mechanical properties. Cold form foils consist of a preformed plastic tray manufactured with aluminum foil closure and include a ‘push-through’ feature for easy use. The cold-formed trays are filled with aqueous medicines and are freeze-dried into individual tablets, which adopt the shape of individual airfoil compartments.

In addition, all-aluminum packs are used for diagnostic products, light-sensitive formulations, and ointments where total barrier performance is required. As product counterfeiting has become an increasingly serious issue, holographic effects are now being used on more and more aluminum foil cold form packs.

The advancing pharmaceutical industry due to the initiatives held by the government authorities, particularly to increase healthcare programs in developing countries, is expected to boost the growth of the global pharmaceutical packaging market, which will simultaneously increase demand for cold form blister packaging. Moreover, pharmaceutical packaging plays a vital role in assuring the safety of the product, offering quality lifesaving drugs, medical devices, and therapeutic treatments.

Global cold form blister packaging market share, by application, 2020 (%)

Innovative and modified packaging designs are in demand to keep drugs and medicines free from all adverse external factors that can modify the physical and chemical properties, biological contamination, degradation, mechanical damage, and counterfeiting. Bioplastics are fast replacing other forms of raw materials, such as glass and aluminum, across pharmaceutical packaging products.

Companies are implementing new technologies and methodologies across packaging product advancements to fulfill the easy-to-use requirements of patients. Some of the major noticeable requirements in the healthcare sector including child-resistant, tamper-evident, senior-friendly, and anti-counterfeit packaging are likely to fuel the efforts by the companies for the advancements in packaging. Such demands are simultaneously triggering the need for protective sealing that controls the damage to shelf life and efficiency of the drug products.

The expansion of the generic market, escalation of financial investment in the healthcare facilities, marketing products through e-commerce, and rapidly growing drug delivery market are further expected to uplift the market growth. Oral ingesting containers, inhalers, nasal sprays, and other similar products have changed the market dynamics and are anticipated to foster the growth of pharmaceutical packaging. Increasing requirements of consumer necessity for convenience and better sealing features, demand for a wide range of products, and improved environmental standards are accelerating the demand for packaging.

Stringent regulatory policies imposed by the World Health Organization (WHO), the Food and Drug Administration (FDA), the European Medicines Agency (EMEA), and other international healthcare authorities regarding packaging and labeling are predicted to further reinforce the market growth. However, raw material availability, volatile price trends, changing health regulations, and scrutinizing healthcare organizations remain bigger challenges for the global market.

Regional Insights

The Asia Pacific region dominated the market with a revenue share of over 30.0% in 2020. China held the largest revenue share of over 30.0% in 2020. The availability of raw materials like aluminum and PVC in the country is supporting the market growth. According to the Government of Canada article, in 2019, China was the world's largest producer with 36 million tones, followed by India, Russia, and Canada. The presence of major players like Shanghai Haishun New Pharmaceutical Packaging Ltd. and Ningbo Dragon Packaging Technology Co., Ltd. in the region is driving the market value.

The rising prevalence of contract manufacturing across developing countries such as China and India is supporting the market growth in the country. The continuously increasing demand for pharmaceutical packaging across the globe is the primary reason for outsourcing packaging services to third-party organizations. Drug manufacturers are looking for such service providers in developing economies because of the easy availability of labor at lower rates.

India is projected to exhibit the fastest growth rate of 7.9% from 2021 to 2028. This is because of the increasing investment in the healthcare sector of the region, along with the favorable government support for the expansion and advancement of the pharmaceutical industry in the country. Additionally, the increasing burden of chronic diseases among the residents is another major factor supporting the growth of the market in the country.

According to the research presented at the 70th Annual Conference of the Cardiological Society of India (CSI) in 2018, one out of five young adults in India has high blood pressure (BP), which is almost more than the U.K.’s population. During the research, the blood pressure of around 180,000 Indian adults was recorded. Among them, 89,210 were between 18 and 39 years old and were the focus of the study.

The presence of major players like Bilcare Limited and Uflex Ltd. in the country is further projected to support the market growth in the country. The continuous product development, coupled with the dedicated R&D centers for the research on future-ready products in the market, is projected to support the market growth.

Key Companies & Market Share Insights

The market is fragmented worldwide, especially across the healthcare sector, increasing competition among players. The players are expanding their reach in order to cater to the rising awareness and increasing demand for cold-form blister packaging in the pharmaceutical market. Players are focusing on the productivity of packaging for the safety and longer shelf life of the packaged products. For instance, Bostik, a French-based manufacturer of adhesive and sealing products, has launched HERBERTS EPS 8760/KN75. It’s a high-performance, smart adhesive particularly developed to improvise the process automation of cold forming blister packaging across the pharmaceutical industry. The market is fragmented and has an amalgamation of medium and large players across the Asia Pacific and other major regions like North America and Europe. Companies are continuously putting efforts to develop more advanced and chronic disease-centric medications for more effective and fast treatment in the near future. The spreading awareness regarding proper treatment in the developing economies among the middle-class population, along with the increasing per capita income, is supporting the demand for cold form blister packaging across the globe. Some prominent players in the global cold form blister packaging market include:

  • Amcor Limited (Bemis Company, Inc.)

  • Constantia Flexibles Group GmbH

  • Bilcare Limited

  • Winpak Ltd.

  • Uflex Ltd.

  • ACG Pharmapack Pvt. Ltd.

  • Svam Packaging Industries Pvt. Ltd.

  • Tekni-Plex, Inc.

  • Essentra plc

  • Ningbo Dragon Packaging Technology Co., Ltd.

  • Rollprint Packaging Products, Inc.

  • R-Pharm Germany GmbH

  • Wasdell Group

  • Shanghai Haishun New Pharmaceutical Packaging Ltd.

Cold Form Blister Packaging Market Report Scope

Report Attribute


Market size value in 2021

USD 3.64 billion

Revenue forecast in 2028

USD 5.69 billion

Growth Rate

CAGR of 6.5% from 2021 to 2028

Base year for estimation


Historical data

2017 - 2019

Forecast period

2021 - 2028

Quantitative units

Revenue in USD million and CAGR from 2021 to 2028

Report coverage

Revenue forecast,company ranking, competitive landscape, growth factors, and trends

Segments covered

Material, application,region

Regional scope

North America; Europe; Asia Pacific; Central & South America; Middle East & Africa

Country scope

U.S.; Canada; Mexico; U.K.; Germany; France; Italy; Spain; China; Japan; India; South Korea; Brazil; Saudi Arabia

Key companies profiled

Amcor Limited (Bemis Company, Inc.); Constantia Flexibles Group GmbH; Bilcare Limited; Winpak Ltd.; Uflex Ltd.; ACG Pharmapack Pvt. Ltd.; Svam Packaging Industries Pvt. Ltd.; Tekni-Plex, Inc.; Essentra plc; Ningbo Dragon Packaging Technology Co., Ltd.; Rollprint Packaging Products, Inc.; R-Pharm Germany GmbH; Wasdell Group; Shanghai Haishun New Pharmaceutical Packaging Ltd.;E. I. du Pont de Nemours and Company

Customization scope

Free report customization (equivalent up to 8 analysts’ working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Segments Covered in the Report

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2017 to 2028. For the purpose of this study, Grand View Research has segmented the global cold form blister packaging market report on the basis of material, application, and region:

  • Material Outlook (Revenue, USD Million, 2017 - 2028)

    • Oriented-polyamide

    • Aluminum

    • Polyvinyl Chloride

    • Polypropylene

    • PE

    • PET

  • Application Outlook (Revenue, USD Million, 2017 - 2028)

    • Healthcare

    • Consumer Products

    • Electronics & Semiconductors

    • Food & Confectionery

    • Others

  • Regional Outlook (Revenue, USD Million, 2017 - 2028)

    • North America

      • U.S.

      • Canada

      • Mexico

    • Europe

      • U.K.

      • Germany

      • France

      • Italy

      • Spain

    • Asia Pacific

      • China

      • Japan

      • India

      • South Korea

    • Central & South America (CSA)

      • Brazil

    • Middle East & Africa (MEA)

      • Saudi Arabia

Frequently Asked Questions About This Report

gvr icn


gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

D&B icon

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon